– UK, London – Smith+Nephew (LON: SN | NYSE: SNN), the global medical technology business, today announced the appointment of Dr. John Ma to its Board as a Non-Executive Director, effective on 17 February 2021.
“We are delighted to have secured a Board colleague with John’s track record growing medical device businesses across China and the wider region. I am confident that his expertise will further help us support the management team’s strategic ambitions.” said Board Chair, Roberto Quarta.
About Dr. John Ma
Dr. John Ma is an established leader within the MedTech industry with a deep knowledge of the Asia-Pacific region and surgical robotics, both significant areas of opportunity for Smith+Nephew.
Since 2019, Dr. John Ma has served as CEO and Chair of Ronovo Surgical, a start-up soft tissue surgical robotics business he founded. His previous executive experience includes SVP, Strategic Growth Initiatives at Intuitive Surgical, President of Fosun Health Holding, and VP and General Manager, Central China for GE Healthcare.
Previous non-executive director experience includes Hong Kong-listed Haier Electronics and Hong Kong and Shanghai-listed Fosun Pharma.
Dr. Ma holds a Ph.D. in Materials Science and Engineering from Wayne State University, USA.
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business that exists to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 17,500+ employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Advanced Wound Management, and Sports Medicine & ENT.
Founded in Hull, UK, in 1856, we now operate in more than 100 countries and generated annual sales of $5.1 billion in 2019. Smith+Nephew is a constituent of the FTSE100.
For more information: https://www.smith-nephew.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.